SCHEMBL2202087

SCHEMBL2202087

CC(c1ccc(N)cc1)(c1ccc(N)cc1)c1ccc(N)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
MAPT P10636 4/20 0.52
MAPK1 P28482 4/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HPGD P15428 1/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KIF11 P52732 1/20 0.46
ACHE P22303 1/20 0.45
ESR1 P03372 2/20 0.44
ESR2 Q92731 2/20 0.44
CYP3A4 P08684 6/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
TDP1 Q9NUW8 4/20 0.42
TP53 P04637 2/20 0.42
ALOX15 P16050 3/20 0.39
LMNA P02545 1/20 0.39
MPO P05164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20869792 0.92 ALDH1A1 (0.46) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL20404581 0.89 ACHE (0.65) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL204220 0.89 ESR1 (0.60) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL836297 0.87 ESR1 (0.64) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL311555 0.85 ALDH1A1 (0.76) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL25286965 0.83 ESR1 (0.54) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL22050358 0.83 CYP3A4 (0.65) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL8199340 0.83 TDP1 (0.70) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL20807017 0.82 ACHE (0.54) ALDH1A1MAPTMAPK1NPC1RAB9A
SCHEMBL676983 0.81 KIF11 (0.52) ALDH1A1MAPTMAPK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4321547-A1 CROSSLINKABLE SYSTEMS Prefere Resins Holding GmbH (DE) 2024-02-14 EP claimed
US-5623023-A BLEND OF EPOXY RESINS, POLYEPOXIDES TAIYO INK MANUFACUTURING CO., LTD. (JP) 1997-04-22 US claimed
CN-117924096-B Method for synthesizing 4, 4'' -triamino triphenylmethane 北京理工大学 2026-05-19 CN disclosed
US-20260077335-A1 SQUARAMIDE COVALENT ORGANIC FRAMEWORKS ExxonMobil Technology and Engineering Company 2026-03-19 US disclosed
CN-117924096-A Method for synthesizing 4, 4'' -triamino triphenylmethane 北京理工大学 2024-04-26 CN disclosed
EP-4321547-A1 CROSSLINKABLE SYSTEMS Prefere Resins Holding GmbH (DE) 2024-02-14 EP disclosed
EP-2033324-B1 MEMBRANES AND METHODS FOR THEIR PREPARATION UNIV BEN GURION (IL) 2016-04-13 EP disclosed
EP-1909142-B1 PHOTOSENSITIVE RESIN COMPOSITION AND ADHESION ENHANCER TORAY INDUSTRIES (JP) 2015-06-24 EP disclosed
US-8710109-B2 Chemically resistant membranes, coatings and films and methods for their preparation BEN GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) 2014-04-29 US disclosed
US-20130203873-A1 CHEMICALLY RESISTANT MEMBRANES, COATINGS AND FILMS AND METHODS FOR THEIR PREPARATION BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY LTD. (IL) 2013-08-08 US disclosed
EP-2128193-B1 POROUS POLYIMIDE IBIDEN CO LTD (JP) 2013-06-19 EP disclosed
EP-1623010-A2 PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE JANSSEN PHARMACEUTICA N.V. (BE) 2006-02-08 EP disclosed
EP-1117102-B1 Method of manufacturing material for forming insulating film JSR CORP (JP) 2005-08-10 EP disclosed
WO-2004096984-A2 PRESERVATION OF RNA IN A BIOLOGICAL SAMPLE JANSSEN PHARMACEUTICA N.V. (BE) 2004-11-11 WO disclosed
US-6642352-B2 Providing a silicon inorganic polymer compound or polyarylenes or polyphenylene ether organic polymer compound, treating the polymeric compound with a zeta-potential producing filter material, and producing curable polymer compound JSR CORPORATION (JP) 2003-11-04 US disclosed
US-6316170-B2 COATING, EXPOSURE, DEVELOPMENT AND HEAT TREATMENT KABUSHIKI KAISHA TOSHIBA (JP) 2001-11-13 US disclosed
US-20010009936-A1 Method of manufacturing material for forming insulating film JSR CORPORATION (JP) 2001-07-26 US disclosed
EP-1117102-A2 Method of manufacturing material for forming insulating film JSR Corporation (JP) 2001-07-18 EP disclosed
US-20010006767-A1 Developing solution and method of forming polyimide pattern by using the developing solution YOSHIAKI KAWAMONZEN 2001-07-05 US disclosed
US-5623023-A BLEND OF EPOXY RESINS, POLYEPOXIDES TAIYO INK MANUFACUTURING CO., LTD. (JP) 1997-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260077335-A1 SQUARAMIDE COVALENT ORGANIC FRAMEWORKS COASY, FGFR3, AQP4 ALDH1A1 1069/4885MAPT 424/4885MAPK1 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.